TickerFactsScreenerDevelopers

Travere Therapeutics, Inc. (TVTX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2011: $10.1K2012: $11.0K2013: $6.00M2014: $18.20M2015: $37.80M2016: $41.00M2017: $99.39M2018: $102.87M2019: $62.44M2020: $84.77M2021: $165.75M2022: $61.69M2023: $58.18M2024: $58.53M2025: $93.03M$93.03M
2011Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$93.03M+58.9%
2024$58.53M+0.6%
2023$58.18M-5.7%
2022$61.69M-62.8%
2021$165.75M+95.5%
2020$84.77M+35.8%
2019$62.44M-39.3%
2018$102.87M+3.5%
2017$99.39M+142.4%
2016$41.00M+8.5%
2015$37.80M+107.7%
2014$18.20M+203.6%
2013$6.00M+54418.2%
2012$11.0K+9.4%
2011$10.1K—